Mental Health DailyResearch. Evidence. Perspective.Published research on Drugs.
A 2026 Taiwanese case series reported VAS pain drops in all 3 adults treated with pregabalin for type I complex regional pain syndrome: 9 to 5, 2 to 1, and 6 to 3 after doses of 75-150 mg/da…
Read articleA 2026 clinical-lab study tested a 77-drug liquid chromatography-tandem mass spectrometry serum screen in 1,021 patients and found that benzodiazepines accounted for 37.9% of all detections,…
Read articleA 2026 individual participant data meta-analysis of 1,721 dementia trial participants linked risperidone to cerebrovascular adverse events, HR 4.11 (95% CI 1.77 to 9.51), and major cardiovas…
Read articleA 2026 iScience study found that 45 days of clomipramine improved spatial, working, and reference memory in female APP/PS1 Alzheimer’s-model mice, apparently by blocking the E3 ubiquitin lig…
Read articleA 2026 cross-sectional study involving 428 employed adults found that poor sleepers reported a median 292.8 mg/day of caffeine, compared with 176.1 mg/day among good sleepers, and total caff…
Read articleA 2026 Scientific Reports paper involving 1,205 participants found that people using GLP-1-style weight-loss medication were judged as less effortful, less moral, less competent, less warm, …
Read articleA 2026 PRISMA-compliant systematic review and meta-analysis in Drug and Alcohol Review consolidated 30 publications covering 202 prevalence estimates from 120,041 South African adolescents: …
Read article
